View More Recent Stories
-
Tenon Medical Reports Third Quarter 2024 Financial Results
-
Tenon Medical Announces Initial Clinical Cases Successfully Completed with Company’s New Catamaran(R) SE SI Joint Fusion System
-
Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results
-
Tenon Medical (TNON) Regains Nasdaq Compliance
-
Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements
-
Tenon Medical (TNON) Announces Issuance of Three U.S. Patents
-
Tenon Medical(R) Announces Issuance of Three U.S. Patents
-
Tenon Medical (TNON) Issues Three Notices of Allowance for Patent Applications from the USPTO
-
Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO
-
Tenon Medical, Inc. Announces Closing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
-
Tenon Medical (TNON) Prices 1.22M Share Offering at $3.68/sh
-
Tenon Medical, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
-
Tenon(R) Medical Announces the Introduction of the Catamaran(R) SE SI Joint Fusion System
-
Tenon Medical (TNON) Files for 1.71M Share and Warrant Offering
-
Tenon Medical (TNON) Halted, News Pending
-
Tenon Medical (TNON) Announces 1:8 Reverse Share Split
-
Tenon Medical Announces 1:8 Reverse Split
-
Tenon Medical (TNON) Announces First Peer Reviewed Publication of the MAINSAIL Study
-
Tenon(R) Medical Announces First Peer Reviewed Publication of the MAINSAIL(TM) Study Analyzing the First 33 Consecutive Patients from an IRB Approved, Prospective, Multi-Centered, Post-Market Clinical
-
Tenon Medical (TNON) Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer
-
Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer
-
Tenon Medical (TNON) Misses Q2 EPS by 102c
-
Tenon Medical, Inc. Announces Timing of Second Quarter 2024 Financial Results
-
Tenon Medical (TNON) Files for Up to 5M Share Offering by Selling Stockholders
